Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07513493 · ClinicalTrials.gov registry record · Phase 4
Pipelle vs the Curved Aspirator Device
A Phase 4 study, sponsored by Maimonides Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 124
- Enrollment target
NCT07513493: Recruiting Phase 4 study, sponsored by Maimonides Medical Center.
NCT07513493 is a Phase 4 study that is actively recruiting participants, run by Maimonides Medical Center. The registered enrollment target is 124 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07513493, a Phase 4 study, is actively recruiting participants, sponsored by Maimonides Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 124 participants
- Enrollment target
Study Summary
The primary aim of this study is to rigorously compare the efficacy of two commonly used endometrial sampling devices, the Pipelle and the Miltex, these devices are standard of care at Maimonides. This primary objective is critical, as the ability to accurately reach the uterine cavity is fundamental to obtaining adequate samples for histopathological evaluation, which is crucial for diagnosing endometrial cancer and other uterine pathologies.
Primary Outcome
defined as the inability to insert the sampler through the external or internal os after two attempts (determined by passing the external os \<6cm)
Interventions
- DEVICE Curved Tip Aspirator
- DEVICE Pipelle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2026-01-02 |
| Est. Completion | 2028-03-31 |
| Phase | Phase 4 |
What NCT07513493 shows while recruiting
NCT07513493 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which Curved Tip Aspirator is the first listed.
NCT07513493 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07513493 about?
NCT07513493 is a clinical study titled "Pipelle vs the Curved Aspirator Device". The primary aim of this study is to rigorously compare the efficacy of two commonly used endometrial sampling devices, the Pipelle and the Miltex, these devices are standard of care at Maimonides. This primary objective is critical, as the ability to accurately reach the uterine cavity is fundamenta...
What is the current status of trial NCT07513493?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 124 participants. The study started on 2026-01-02. Estimated completion is 2028-03-31.
What interventions are being tested in trial NCT07513493?
The interventions under investigation include: Curved Tip Aspirator (DEVICE), Pipelle (DEVICE).
Who is sponsoring clinical trial NCT07513493?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07513493's enrollment target sits among peer trials
124 656th of 2000 higher than 1,339 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI